Baxter International Inc. (NYSE:BAX) is planning to offload its U.S.-based generic injectables business to British drug firm Hikma Pharmaceuticals PLC (LSE:HIK). The deal is worth about $112 million to the Deerfield, Illinois-based company, according to a statement. The agreement is comprised of Hikma acquisition of Baxter’s injectable products in vials and ampules, which are marketed […]
The average American hospital barely breaks even, according to Forbes' first survey of America's most profitable hospitals. But the most profitable hospital in the country -- 235-bed Flowers Medical Center in Dothan, Alabama -- recorded a 53 percent operating margin and belongs to the for-profit Community Health Systems (NYSE: CYH) chain in Brentwood, Tennessee.
Former CEO and company chairman Brad Nutter announces retirement from the Braintree, Mass.-based blood management company after seven years. Brad Nutter, the turnaround artist who helped pump new life into Haemonetics Corp. (NYSE:HAE) as CEO and later chairman of the board, said he will retire from the company’s board of directors effective November 1, 2010. […]
The U.S. Food & Drug Administration said it is requiring nine medical device companies to conduct postmarket analysis on a connection between needless connectors and higher rates of blood stream infections. In a notice posted on the Centers for Devices and Radiological Health web site, officials said that the agency is “aware of information that […]
Baxter International Inc.’s (NYSE:BAX) profits fell 9 percent due to higher costs and big write-down from a settlement with the government of Greece. The Deerfield, Ill.-based medical device and vaccine maker posted net income of $535 million for the three months ended June 30, down 9 percent from $587 million during the same period last […]
The U.S. Food & Drug Administration’s recall covers as many as 200,000 of Baxter International Inc.’s Colleague infusion pumps. The Food & Drug Administration issued its final order for the U.S. recall of Baxter International Inc.’s (NYSE:BAX) Colleague infusion pumps. The federal watchdog is requiring the Deerfield, Ill.-based company to provide transition guide for hospitals […]
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
The Food & Drug Administration warns Baxter Healthcare Corp. about problems with its HomeChoice peritoneal dialysis systems after reports of patients developing peritonitis. The Food & Drug Administration warned Baxter Healthcare Corp. (NYSE:BAX) that it has 15 days to respond to the watchdog agency’s concerns about its HomeChoice peritoneal dialysis systems, after reports surfaced of […]
The medical device industry spent at least $20 million to lobby lawmakers and federal agencies during the first quarter. The medical device industry once again spent big bucks to ensure its voice was heard in Washington during the first quarter, dropping more than $20 million on lobbying efforts for health issues at the U.S. House […]
Baxter International Inc. (NYSE:BAX) took a $39 million hit to its bottom line during the first quarter, blaming the healthcare reform act’s added tax burden and lowering its full-year guidance. The Deerfield Park, Ill.-based medical products giant posted sales of $3.14 billion during the three months ended March 31, up 11.2 percent compared with $2.82 […]
Baxter International Inc. (NYSE:BAX) named Ludwig Hantson president of its international operations, effective May 3. The Deerfield, Ill.-based medical products conglomerate said expanding its global footprint is a “key growth driver” for the company. Hantson’s pedigree is stamped by years in the pharmaceutical industry. He was CEO of Novartis Pharmaceuticals Corp.’s (NYSE:NVS) Pharma North America […]
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Medical device makers, health information technology providers and AdvaMed together spent more than $20 million lobbying Congress, the White House and the Food & Drug Administration during the fourth quarter.
The FDA posted notice of a Class I recall of a hemodialysis system distributed by Baxter International Inc., warning that in extreme cases the machine's defect could result in serious injuries or death.